Request Call Back

Contact Us

Pharmaceutical Whistleblower
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Name of company or organization:

General description of allegation:

Was described allegation a Medicare or Medicaid fraud?

Year in which allegations started:

Year in which allegations ended:

Basis of knowlege: 

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Pharmaceutical Whistleblower

Whistleblowers Receive Financial Incentives Under the False Claims Act

Whistleblowers Receive Financial Incentives Under the False Claims Act

Whistleblowers Receive Financial Incentives Under the False Claims Act

In recent years many pharmaceutical employees have come forward to report fraudulent billing, illegal marketing techniques and undisclosed drug side effects. These courageous people known as whistleblowers have helped the federal government recover billions of dollars that were obtained illegally by pharmaceutical companies. More importantly whistleblowers have helped save the lives of thousands of prescription drug users that were previously unaware of their medication's side effects.

Some whistleblowers can become quite wealthy indeed. In 2009, John Kopchinski, a Gulf War veteran and former Pfizer sales representative, earned more than $51.5 million as a result of his whistleblower lawsuit against the world's biggest drug maker and the record penalty the company had to payto the U.S. government for marketing offenses.

Kopchinski, appalled by Pfizer's tactics in selling the pain drug Bextra, filed a "qui tam" lawsuit in 2003, sparking federal and state probes that led to an eventual agreement by the company to pay $2.3 billion in civil and criminal penalties and plead guilty to a felony charge for promoting Bextra and 12 other drugs for unapproved uses and doses.

More than $30 Billion Recovered

The Justice Department last year celebrated the 25th anniversary of the 1986 amendments to the False Claims Act.

“In the last quarter century, the False Claims Act’s success has been unparalleled, with more than $30 billion dollars recovered since it was amended in 1986 and $8.8 billion since January 2009,” said Attorney General Eric Holder at an event marking the day. “The Department of Justice has achieved record recoveries in recent years and we will continue to aggressively pursue those who would take advantage of their fellow citizens.” Legal Help For Victims Affected By Pharmaceutical Whistleblower

If you are a current or former pharmaceutical company employee and have information on any illegal activities, please fill out the form at the right for a free case evaluation by a qualified attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


Pharmaceutical WhistleblowerRSS Feed

Ketek case keeps glare on reform

Feb 14, 2007 | The Star Ledger
The Food and Drug Administration's Missteps in Approving the Controversial Antibiotic The Food and Drug Administration's missteps in approving the controversial antibiotic Ketek were cited at a congressional hearing yesterday as further evidence of the need for major drug safety reform. FDA whistle-blowers, medical experts and members of Congress said the FDA in 2004 approved Ketek, since linked to liver failures, despite serious safety warnings from scientific reviewers and evidence of...

Ex-J&J officer files lawsuit as whistle-blower

Dec 15, 2006 | Star Ledger
The former chief medical officer for a unit of Johnson & Johnson has filed a whistle-blower lawsuit against the company, claiming he was fired for seeking product recalls of several faulty medical devices. Joel Lippman said he was terminated from his post at Ethicon in May, after working at the subsidiary for almost six years. Before that, Lippman, 52, of Warren, helped oversee clinical trials for a decade at another J&J unit, Ortho-McNeil Pharmaceuticals.  Lippman claims he...

Chief Medical Officer Blows Whistle On Johnson & Johnson

Dec 13, 2006 |
Johnson & Johnson subsidiary Ethicon fired its chief medical officer because of his insistence that unsafe medical products be recalled, Dr. Joel Lippman claims in Middlesex County Court. Lippman claims that during 15 years in high-ranking medical positions at Ethicon and Ortho McNeil, another J&J subsidiary, Johnson & Johnson repeatedly released or refused to recall dangerous products to which he objected, including the Ortho-Evra birth control patch and Intergel. Both products...

Lawmaker Alleges FDA, Merck Collaborated

Jul 19, 2006 | AP
A federal health official worked with drug maker Merck to discredit a government whistleblower who publicized safety risks associated with the painkiller Vioxx, a lawmaker alleged Wednesday in seeking an investigation. Sen. Charles Grassley, R-Iowa, asked the inspector general at the Health and Human Services Department to probe whether the Food and Drug Administration and Merck acted in concert to call into question the safety findings made by Dr. David Graham, an FDA drug safety official. ...

Judge orders FDA whistleblower to testify

Mar 15, 2006 | AP
The Food and Drug Administration whistleblower who has criticized the agency's handling of Vioxx will be deposed, a judge ruled, offering evidence that could aid thousands of lawsuits over the withdrawn pain killer. A federal judge refused to grant a government motion to quash plaintiffs' lawyers subpoena of drug reviewer Dr. David Graham, who testified at a 2004 Congressional hearing that the Merck & Co. drug caused as many as 160,000 heart attacks and strokes. Graham questioned the...

More Pharmaceutical Whistleblower News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo